Alpha-Tocopherol Protects Human Dermal Fibroblasts by Modulating Nitric Oxide Release, Mitochondrial Function, Redox Status, and Inflammation
Skin Pharmacology and Physiology · 2022 · 35 (1) · 1-12
DOI: 10.1159/000517204 ↗Kurz gefasst
Fachartikel in der Zeitschrift Skin Pharmacology and Physiology, online erschienen am 08.07.2021. Verfasst von Lara Camillo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Science, Dermatologic Unit, University of Eastern Piedmont, Novara, Italy. Hauptthemen laut MEDLINE: Nitric Oxide, alpha-Tocopherol. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 58 Literaturangaben.
Abstract (Originalsprache)
Background
The altered balance between oxidants/antioxidants and inflammation, changes in nitric oxide (NO) release, and mitochondrial function have a role in skin aging through fibroblast modulation. Tocopherol is promising in counteracting the abovementioned events, but the effective mechanism of action needs to be clarified.
Objective
The aim of this study was to examine the effects of α-tocopherol on cell viability/proliferation, NO release, mitochondrial function, oxidants/antioxidants, and inflammation in human dermal fibroblasts (HDF) subjected to oxidative stress.
Methods
HDF were treated with H2O2 in the presence or absence of 1–10 μM α-tocopherol. Cell viability, reactive oxygen species (ROS), NO release, and mitochondrial membrane potential were measured; glutathione (GSH), superoxide dismutase (SOD)-1 and -2, glutathione peroxidase-1 (GPX-1), inducible NO synthase (iNOS), and Ki-67 were evaluated by RT-PCR and immunofluorescence; cell cycle was analyzed using FACS. Pro- and anti-inflammatory cytokine gene expression was analyzed through qRT-PCR. Results: α-Tocopherol counteracts H2O2, although it remains unclear whether this effect is dose dependent. Improvement of cell viability, mitochondrial membrane potential, Ki-67 expression, and G0/G1 and G2/M phases of the cell cycle was observed. These effects were accompanied by the increase of GSH content and the reduction of SOD-1 and -2, GPX-1, and ROS release. Also, iNOS expression and NO release were inhibited, and pro-inflammatory cytokine gene expression was decreased, confirming the putative role of α-tocopherol against inflammation. Conclusion: α-Tocopherol exerts protective effects in HDF which underwent oxidative stress by modulating the redox status, inflammation, iNOS-dependent NO release, and mitochondrial function. These observations have a potential role in the prevention and treatment of photoaging-related skin cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Science, Dermatologic Unit, University of Eastern Piedmont, Novara, Italy.
- Laboratory of Physiology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
- Azienda Ospedaliera Universitaria Maggiore della Carità, Novara, Italy.
Zitieren
APA
Camillo, L., Grossini, E., Farruggio, S., Marotta, P., Gironi, L. C., Zavattaro, E., & Savoia, P. (2022). Alpha-Tocopherol Protects Human Dermal Fibroblasts by Modulating Nitric Oxide Release, Mitochondrial Function, Redox Status, and Inflammation. Skin Pharmacology and Physiology, 35(1), 1-12. https://doi.org/10.1159/000517204
Vancouver
Camillo L, Grossini E, Farruggio S, Marotta P, Gironi LC, Zavattaro E, et al. Alpha-Tocopherol Protects Human Dermal Fibroblasts by Modulating Nitric Oxide Release, Mitochondrial Function, Redox Status, and Inflammation. Skin Pharmacology and Physiology. 2022;35(1):1-12. doi:10.1159/000517204
BibTeX
@article{Camillo2022,
author = {Camillo, Lara and Grossini, Elena and Farruggio, Serena and Marotta, Patrizia and Gironi, Laura Cristina and Zavattaro, Elisa and Savoia, Paola},
title = {Alpha-Tocopherol Protects Human Dermal Fibroblasts by Modulating Nitric Oxide Release, Mitochondrial Function, Redox Status, and Inflammation},
journal = {Skin Pharmacology and Physiology},
year = {2022},
volume = {35},
number = {1},
pages = {1--12},
doi = {10.1159/000517204}
}
EUVIMED